{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:32:46Z","timestamp":1770982366846,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":1801,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1093\/annonc\/mdu459","type":"journal-article","created":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T08:11:02Z","timestamp":1412237462000},"page":"300-306","source":"Crossref","is-referenced-by-count":80,"title":["Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper"],"prefix":"10.1016","volume":"26","author":[{"given":"P.G.","family":"Casali","sequence":"first","affiliation":[]},{"given":"P.","family":"Bruzzi","sequence":"additional","affiliation":[]},{"given":"J.","family":"Bogaerts","sequence":"additional","affiliation":[]},{"given":"J.-Y.","family":"Blay","sequence":"additional","affiliation":[]},{"given":"M.","family":"Aapro","sequence":"additional","affiliation":[]},{"given":"A.","family":"Adamous","sequence":"additional","affiliation":[]},{"given":"A.","family":"Berruti","sequence":"additional","affiliation":[]},{"given":"J.-Y.","family":"Blay","sequence":"additional","affiliation":[]},{"given":"J.","family":"Bogaerts","sequence":"additional","affiliation":[]},{"given":"J.","family":"Bressington","sequence":"additional","affiliation":[]},{"given":"B.","family":"Bruzzi","sequence":"additional","affiliation":[]},{"given":"R.","family":"Capocaccia","sequence":"additional","affiliation":[]},{"given":"F.","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"P.G.","family":"Casali","sequence":"additional","affiliation":[]},{"given":"J.E.","family":"Celis","sequence":"additional","affiliation":[]},{"given":"A.","family":"Cervantes","sequence":"additional","affiliation":[]},{"given":"F.","family":"Ciardiello","sequence":"additional","affiliation":[]},{"given":"C.","family":"Claussen","sequence":"additional","affiliation":[]},{"given":"M.","family":"Coleman","sequence":"additional","affiliation":[]},{"given":"S.","family":"Comis","sequence":"additional","affiliation":[]},{"given":"S.","family":"Craine","sequence":"additional","affiliation":[]},{"given":"D.","family":"De Boltz","sequence":"additional","affiliation":[]},{"given":"F.","family":"De Lorenzo","sequence":"additional","affiliation":[]},{"given":"A.P.","family":"Dei Tos","sequence":"additional","affiliation":[]},{"given":"G.","family":"Gatta","sequence":"additional","affiliation":[]},{"given":"J.","family":"Geissler","sequence":"additional","affiliation":[]},{"given":"R.","family":"Giuliani","sequence":"additional","affiliation":[]},{"given":"E.","family":"Grande","sequence":"additional","affiliation":[]},{"given":"A.","family":"Gronchi","sequence":"additional","affiliation":[]},{"given":"S.","family":"Jezdic","sequence":"additional","affiliation":[]},{"given":"B.","family":"Jonsson","sequence":"additional","affiliation":[]},{"given":"L.","family":"Jost","sequence":"additional","affiliation":[]},{"given":"H.","family":"Keulen","sequence":"additional","affiliation":[]},{"given":"D.","family":"Lacombe","sequence":"additional","affiliation":[]},{"given":"G.","family":"Lamory","sequence":"additional","affiliation":[]},{"given":"Y.","family":"Le Cam","sequence":"additional","affiliation":[]},{"given":"S.","family":"Leto di Priolo","sequence":"additional","affiliation":[]},{"given":"L.","family":"Licitra","sequence":"additional","affiliation":[]},{"given":"F.","family":"Macchia","sequence":"additional","affiliation":[]},{"given":"A.","family":"Margulies","sequence":"additional","affiliation":[]},{"given":"S.","family":"Marreaud","sequence":"additional","affiliation":[]},{"given":"G.","family":"McVie","sequence":"additional","affiliation":[]},{"given":"S.","family":"Narbutas","sequence":"additional","affiliation":[]},{"given":"K.","family":"Oliver","sequence":"additional","affiliation":[]},{"given":"N.","family":"Pavlidis","sequence":"additional","affiliation":[]},{"given":"J.","family":"Pelouchova","sequence":"additional","affiliation":[]},{"given":"G.","family":"Pentheroudakis","sequence":"additional","affiliation":[]},{"given":"M.","family":"Piccart","sequence":"additional","affiliation":[]},{"given":"M.A.","family":"Pierotti","sequence":"additional","affiliation":[]},{"given":"G.","family":"Pravettoni","sequence":"additional","affiliation":[]},{"given":"K.","family":"Redmond","sequence":"additional","affiliation":[]},{"given":"P.","family":"Riegman","sequence":"additional","affiliation":[]},{"given":"M.P.","family":"Ruffilli","sequence":"additional","affiliation":[]},{"given":"D.","family":"Ryner","sequence":"additional","affiliation":[]},{"given":"S.","family":"Sandrucci","sequence":"additional","affiliation":[]},{"given":"M.","family":"Seymour","sequence":"additional","affiliation":[]},{"given":"V.","family":"Torri","sequence":"additional","affiliation":[]},{"given":"A.","family":"Trama","sequence":"additional","affiliation":[]},{"given":"S.","family":"Van Belle","sequence":"additional","affiliation":[]},{"given":"G.","family":"Vassal","sequence":"additional","affiliation":[]},{"given":"M.","family":"Wartenberg","sequence":"additional","affiliation":[]},{"given":"C.","family":"Watts","sequence":"additional","affiliation":[]},{"given":"A.","family":"Wilson","sequence":"additional","affiliation":[]},{"given":"W.","family":"Yared","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdu459_bb0010","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","article-title":"Rare cancers are not so rare: the rare cancer burden in Europe","volume":"47","author":"Gatta","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdu459_bb0015","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/bmj.304.6834.1099","article-title":"Decision analysis in medicine","volume":"304","author":"Thornton","year":"1992","journal-title":"Br Med J"},{"key":"10.1093\/annonc\/mdu459_bb0020","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nrd4129","article-title":"The risks of risk aversion in drug regulation","volume":"12","author":"Eichler","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1093\/annonc\/mdu459_bb0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/107327480701400209","article-title":"Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design","volume":"14","author":"Behera","year":"2007","journal-title":"Cancer Control"},{"key":"10.1093\/annonc\/mdu459_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/bmj.327.7405.47","article-title":"Strategy for randomised clinical trials in rare cancers","volume":"327","author":"Tan","year":"2003","journal-title":"Br Med J"},{"key":"10.1093\/annonc\/mdu459_bb0035","first-page":"423","article-title":"Principles of clinical trial design","volume":"15","author":"Piantadosi","year":"1988","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdu459_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-90-481-9485-8_11","article-title":"Clinical trials and rare diseases","volume":"686","author":"Gerss","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1093\/annonc\/mdu459_bb0045","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.2013.53.8009","article-title":"American Society of Clinical Oncology Perspective: raising the bar for clinical trials by defining clinically meaningful outcomes","volume":"32","author":"Ellis","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdu459_bb0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jnci\/djq493","article-title":"Demystify statistical significance\u2014time to move on from the p value to Bayesian analysis","volume":"103","author":"Lee","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdu459_bb0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrclinonc.2011.165","article-title":"Adaptive clinical trials in oncology","volume":"9","author":"Berry","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1093\/annonc\/mdu459_bb0060","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ejca.2011.12.024","article-title":"Adaptive designs at European Organisation for Research and Treatment of Cancer (EORTC) with a focus on adaptive sample size re-estimation based on interim-effect size","volume":"48","author":"Mauer","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdu459_bb0065","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1002\/cncr.24628","article-title":"Bayesian statistics in oncology: a guide for the clinical investigator","volume":"115","author":"Adamina","year":"2009","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdu459_bb0070","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/bmj.311.7020.1621","article-title":"Clinical trials and rare diseases: a way out of a conundrum","volume":"311","author":"Lilford","year":"1995","journal-title":"Br Med J"},{"key":"10.1093\/annonc\/mdu459_bb0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrclinonc.2010.43","article-title":"Biomarkers and surrogate end points\u2014the challenge of statistical validation","volume":"7","author":"Buyse","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1093\/annonc\/mdu459_bb0080","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/cpt196126709","article-title":"Meaningful clinical classification of therapeutic responses to anticancer drugs","volume":"2","author":"Karnofsky","year":"1961","journal-title":"Clin Pharmac Ther"},{"key":"10.1093\/annonc\/mdu459_bb0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdu459_bb0090","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1023\/A:1008497110734","article-title":"Phase I and II trials of novel anti-cancer agents: endpoints, efficacy and existentialism. The Michel Clavel Lecture, held at the 10th NCI-EORTC Conference on New Drugs in Cancer Therapy, Amsterdam, 16\u201319 June 1998","volume":"9","author":"Eisenhauer","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdu459_bb0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/978-90-481-9485-8_25","article-title":"Creating a European Union framework for actions in the field of rare diseases","volume":"686","author":"Moliner","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1093\/annonc\/mdu459_bb0100","doi-asserted-by":"crossref","first-page":"f4465","DOI":"10.1136\/bmj.f4465","article-title":"How should clinical trial data be shared?","volume":"347","author":"Tucker","year":"2013","journal-title":"Br Med J"},{"key":"10.1093\/annonc\/mdu459_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1200\/JOP.2013.001204","article-title":"Second-opinion pathologic review is a patient safety mechanism that helps reduce error and decrease waste","volume":"10","author":"Middleton","year":"2014","journal-title":"J Oncol Pract"},{"key":"10.1093\/annonc\/mdu459_bb0110","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.5858\/arpa.2012-0571-OA","article-title":"Histopathologic diagnosis of pediatric neoplasms: a review of international consultations","volume":"137","author":"Santiago","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1093\/annonc\/mdu459_bb0115","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/annonc\/mdr610","article-title":"Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions","volume":"23","author":"Ray-Coquard","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdu459_bb0120","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/clpt.2011.345","article-title":"Adaptive licensing: taking the next step in the evolution of drug approval","volume":"91","author":"Eichler","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/annonc\/mdu459_bb0125","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/annonc\/mdm517","article-title":"The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO)","volume":"18","author":"Casali","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdu459_bb0130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/phe\/phr020","article-title":"Can broad consent be informed consent?","volume":"4","author":"Sheehan","year":"2011","journal-title":"Publ Health Ethics"},{"key":"10.1093\/annonc\/mdu459_bb0135","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ejhg.2012.282","article-title":"Broad consent versus dynamic consent in biobank research: is passive participation an ethical problem?","volume":"21","author":"Steinsbekk","year":"2013","journal-title":"Eur J Hum Gen"},{"key":"10.1093\/annonc\/mdu459_bb0140","article-title":"Cancer registration, public health and the reform of the European data protection framework: abandoning or improving European public health research?","author":"Andersen","year":"2013","journal-title":"Eur J Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419313705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419313705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/2\/300\/19480209\/mdu459.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:45:37Z","timestamp":1624520737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419313705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0923753419313705"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdu459","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}